MedTrace Logo

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

NCT00730756 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2017-04-06

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot study is to compare the effects (effectiveness and safety)of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]) with a placebo nasal spray for the treatment of irritant (non-allergic) rhinitis.

Conditions

  • Rhinitis, Allergic, Perennial

Interventions

DRUG

Fluticasone Furoate Nasal Spray

Fluticasone furoate nasal spray 110mcg intranasally once daily for 4 weeks

OTHER

Placebo Nasal Spray

Matching placebo nasal spray intranasally once daily for 4 weeks

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730756 on ClinicalTrials.gov